Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
[Immune response of heparinase gene modified dendritic cell-based vaccine on gastric cancer cells]
Antigen-independent immune responses after dendritic cell vaccination
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
[Successful immunotherapy combined with hyperthermia therapy for cancer patients]
Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Recent advances in immunotherapy for human glioma
A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia
Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
Hyperthermia and immunity. A brief overview
Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells
In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
Vaccination therapy in prostate cancer
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
[Clinical impact of locoregional hyperthermia in gynecological oncology]
Current status of immunotherapy in B cell malignancies